Rare cancer drugs budget underspent by nearly half

By 2011-06-16T06:42:00

Health Pills

Only 56 per cent of the money allocated for cancer drugs normally unavailable on the NHS was spent in the first six months of a high profile fund, a report has found.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here